Shares of Profusa (PFSA) hit a record low on Thursday, crashing 28% after the biotech company announced its second reverse ...

That is a big risk investors take when trying to find the winners and losers within the biotech sector. While we made the ...

Analysts have given Alnylam Pharmaceuticals an average price target of $436.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

It has been a banner year for biotech buyouts, and these are two of the prime targets.

The heart-drug developer sent a new signal to biotech investors about what Wall Street is willing to fund in 2026. That is ...

It might pull it off, provided several things fall right in place.

In interviews as well as a panel at BIO’s annual meeting, investors and life sciences bankers predicted an acceleration in ...

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.

Vera Therapeutics Inc. (NASDAQ:VERA) is one of the 8 Hidden Multibagger Stocks to Buy Now. On June 11, Wells Fargo reiterated its Buy rating on Vera Therapeutics Inc.

Arcutis doubled revenue last year while Vertex delivered strong profits and cash flow. Explore how each company stacks up on ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...